1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research & Forecasting

• 2.1. Research Methodology
  • 2.1.1. Research Process
  • 2.1.2. Research Framework
  • 2.1.3. Research Reliability & Validity
  • 2.1.4. Research Assumptions
• 2.2. Forecasting Methodology
• 2.3. Research Outcome
  • 2.3.1. Competitive Strategic Window
    • 2.3.1.1. Leverage Zone
    • 2.3.1.2. Vantage Zone
    • 2.3.1.3. Speculative Zone
    • 2.3.1.4. Bottleneck Zone
  • 2.3.2. FPNV Positioning Matrix
    • 2.3.2.1. Quadrants
    • 2.3.2.1.1. Forefront
    • 2.3.2.1.2. Pathfinders
    • 2.3.2.1.3. Niche
    • 2.3.2.1.4. Vital
    • 2.3.2.2. Business Strategy
    • 2.3.2.2.1. Business Growth
    • 2.3.2.2.2. Industry Coverage
    • 2.3.2.2.3. Financial Viability
    • 2.3.2.2.4. Channel Support
    • 2.3.2.3. Product Satisfaction
    • 2.3.2.3.1. Value for Money
    • 2.3.2.3.2. Ease of Use
    • 2.3.2.3.3. Product Features
    • 2.3.2.3.4. Customer Support

    3. Executive Summary

    • 3.1. Outlook in the Gene Therapy Market
    • 3.2. Opportunities in the Gene Therapy Market
    • 3.3. Geographical Analysis in the Gene Therapy Market

    4. Premium Insight

    • 4.1. Market Connectivity
    • 4.2. Market Dynamics
      • 4.2.1. Drivers
        • 4.2.1.1. Significant way of treatment to eradicates the practice of surgery, drugs, or other procedures that lead to side effects on the health of individuals
        • 4.2.1.2. Innovation in gene therapy for rare & cardiovascular diseases treatment coupled with the awareness regarding the ability of gene therapy
        • 4.2.1.3. Application in the treatment of various diseases such as cancer, haemophilia, parkinson’s disease, and HIV
        • 4.2.1.4. Government support and ethical acceptance of gene therapy for cancer treatment
      • 4.2.2. Restraints
        • 4.2.2.1. High cost associated with the gene therapies
      • 4.2.3. Opportunities
        • 4.2.3.1. Upsurge in a number of gene therapy treatment centers in developed countries
        • 4.2.3.2. Increasing adoption for gene therapy for the oncological disorder
        • 4.2.3.3. Growing strategic alliances and ongoing research for orphan diseases
      • 4.2.4. Challenges
        • 4.2.4.1. Potential disorders associated with the immune response
    • 4.3. Porter’s Five Forces Analysis
      • 4.3.1. Threat of New Entrants
      • 4.3.2. Threat of Substitutes
      • 4.3.3. Bargaining Power of Customers
      • 4.3.4. Bargaining Power of Suppliers
      • 4.3.5. Industry Rivalry
    • 4.4. Industry Trends

    5. Global Gene Therapy Market, by Type

    • 5.1. Overview
    • 5.2. Market Sizing & Forecasting
    • 5.3. Antigen Gene Therapy
    • 5.4. Cancer Gene Therapy
    • 5.5. Cytokine Gene Therapy
    • 5.6. Suicide Gene Therapy
    • 5.7. Tumor Suppressor Gene Therapy

    6. Global Gene Therapy Market, by Vector Type

    • 6.1. Overview
    • 6.2. Market Sizing & Forecasting
    • 6.3. Non-viral Vectors
    • 6.4. Viral Vectors

    7. Global Gene Therapy Market, by Application

    • 7.1. Overview
    • 7.2. Market Sizing & Forecasting
    • 7.3. Cardiovascular Diseases
    • 7.4. Genetic Diseases
    • 7.5. Infectious Diseases
    • 7.6. Neurological Diseases
    • 7.7. Oncological Disorders

    8. Global Gene Therapy Market, by Geography

    • 8.1. Americas
      • 8.1.1. Overview
      • 8.1.2. Market Sizing & Forecasting
      • 8.1.3. Argentina
      • 8.1.4. Canada
      • 8.1.5. Mexico
      • 8.1.6. United States
    • 8.2. Asia-Pacific
      • 8.2.1. Overview
      • 8.2.2. Market Sizing & Forecasting
      • 8.2.3. Australia
      • 8.2.4. China
      • 8.2.5. India
      • 8.2.6. Japan
    • 8.3. Europe, Middle East & Africa
      • 8.3.1. Overview
      • 8.3.2. Market Sizing & Forecasting
      • 8.3.3. France
      • 8.3.4. Germany
      • 8.3.5. Italy
      • 8.3.6. Spain
      • 8.3.7. United Kingdom

    9. Competitive Landscape

    • 9.1. FPNV Positioning Matrix for Global Gene Therapy Market
    • 9.2. Market Vendor Ranking Analysis for Global Gene Therapy Market
    • 9.3. Competitive News Feed Analysis for Global Gene Therapy Market

    10. Company Usability Profiles

    • 10.1. Achieve Life Sciences, Inc.
      • 10.1.1. Overview
      • 10.1.2. Strategy
      • 10.1.3. SWOT
    • 10.2. Adaptimmune
      • 10.2.1. Overview
      • 10.2.2. Strategy
      • 10.2.3. SWOT
    • 10.3. Bluebird bio, Inc.
      • 10.3.1. Overview
      • 10.3.2. Strategy
      • 10.3.3. SWOT
    • 10.4. Gilead
      • 10.4.1. Overview
      • 10.4.2. Strategy
      • 10.4.3. SWOT
    • 10.5. Merck & Co., Inc
      • 10.5.1. Overview
      • 10.5.2. Strategy
      • 10.5.3. SWOT
    • 10.6. AGTC
    • 10.7. Abeona Therapeutics, Inc.,
    • 10.8. Audentes Therapeutics
    • 10.9. Biogen
    • 10.10. Editas Medicine
    • 10.11. Novartis
    • 10.12. Orchard Therapeutics
    • 10.13. Spark Therapeutics

    11. Appendix

    • 11.1. Discussion Guide
    • 11.2. Top Reports
      • 11.2.1. Global Wireless Display Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      • 11.2.2. Global Smart TV Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      • 11.2.3. Global Head-Up Display Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      • 11.2.4. Global Fall Detection System Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

The Global Gene Therapy Market is expected to grow from USD 1,636.49 Million in 2018 to USD 6,436.64 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 21.60%.

The positioning of the Global Gene Therapy Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Gene Therapy Market including are Achieve Life Sciences, Inc., Adaptimmune, Bluebird bio, Inc., Gilead, Merck & Co., Inc, Abeona Therapeutics, Inc.,, AGTC, Audentes Therapeutics, Biogen, Editas Medicine, Novartis, Orchard Therapeutics, and Spark Therapeutics.

On the basis of Type, the Global Gene Therapy Market is studied across Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy, Suicide Gene Therapy, and Tumor Suppressor Gene Therapy.

On the basis of Vector Type, the Global Gene Therapy Market is studied across Non-viral Vectors and Viral Vectors.

On the basis of Application, the Global Gene Therapy Market is studied across Cardiovascular Diseases, Genetic Diseases, Infectious Diseases, Neurological Diseases, and Oncological Disorders.

For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.

In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on Gene Therapy offered by the key players in the Global Gene Therapy Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Gene Therapy Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Gene Therapy Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Gene Therapy Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Gene Therapy Market

The report answers questions such as:
1. What is the market size of Gene Therapy market in the Global?
2. What are the factors that affect the growth in the Global Gene Therapy Market over the forecast period?
3. What is the competitive position in the Global Gene Therapy Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Gene Therapy Market?
5. What are the opportunities in the Global Gene Therapy Market?
6. What are the modes of entering the Global Gene Therapy Market?